Infectious Disease Doctors in Greenville, MS Accepting Medicare

1 Infectious Disease doctors found. Showing 1 - 1

Satwinder Singh, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 344 Arnold Ave, Greenville, MS 38701 Phone: 662-725-6730    Fax: 662-725-6735

News Archive

Vertex VX-770 Phase 3 STRIVE study for cystic fibrosis demonstrates improvements in lung function

Vertex Pharmaceuticals Incorporated today announced the final results from its pivotal Phase 3 STRIVE study that evaluated VX-770, a medicine in development that targets the defective protein that causes cystic fibrosis (CF).

Research roundup: High rates of postdischarge complications; Prescriptions refilled even after discontinued

The authors note that hospitals need detailed data about postdischarge (PD) complications among surgical patients in order to develop "appropriate quality improvement interventions and potentially avoid reimbursement penalties." In attempt to bridge this knowledge gap, researchers from Yale and Stanford Universities evaluated procedure types, rates and risk factors for PD complications occurring within 30 days after 21 groups of inpatient general surgery procedures for more than 500,000 patients.

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

Combination of bortezomib and panobinostat shows promise against advanced MM

When the targeted drug bortezomib stops working in patients with advanced multiple myeloma, the patients survive only an average of five months longer. But a phase 2 clinical trial has shown that pairing bortezomib with an experimental drug, panobinostat, may be a promising new treatment for such patients, Dana-Farber Cancer Institute researchers say.

Read more Medical News

› Verified 5 days ago